Breaking News

Sun Hung Kai's Thomas Kwok Sentenced to 5 Years in Jail

European Drug Group to Require Disclosing Payments to Doctors

Drugmakers operating in Europe must disclose payments made to doctors starting in 2016 in an effort to boost transparency and make patients aware of possible conflicts of interest.

The new ethical code requires all members of the European Federation of Pharmaceutical Industries and Associations to disclose payments made in 2015 by 2016, the trade group said in a statement yesterday.

Each company must reveal names of health-care professionals and associations that have received payments, the amounts, and the types of relationships on their websites or on a common website, EFPIA said. The rule follows a similar U.S. provision in President Barack Obama’s health law.

“This is an important step for our industry, as we demonstrate our commitment to transparency and secure the trust of the patients our industry serves,” Richard Bergstroem, director general of EFPIA, said in the statement.

The Association of the British Pharmaceutical Industry started publishing aggregate totals in May of payments made last year to health-care professionals.

To contact the reporter on this story: Makiko Kitamura in London at

To contact the editor responsible for this story: Phil Serafino at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.